biotech boom will be bigger than dotcom boom, page-19

At the risk of sounding repetitive I have to suggest obj.
4cents market cap of 13 million or so.
First class management and scientific staff.
Poached one scientist from Bayer.
Passed phase 1.Close to passing phase 2.Entering vaccine trials.Presentation to symposium on pain and inflammation.
Stock very tightly held.Top 20s hold 43%.Large investment house rumoured to control 200,000,000 on behalf of their clients.
Only 11 months old or so and progressing well.Rumoured to be in discussion with 2 large OS pharmaceutical companies.
Completed most of phase 2 objectives.Entering industry worth $8 billion US$ per year and growing at 28%.
At cutting edge and at rock bottom price.Doesnt appear to be any downside.If you are correct that there is going to be a biotech boom then you are crazy not to buy these at 4cents and hold them.
Do your own research and read the announcements and make your own decision.I hold OBJ.